Health Data Analytics Institute

Overview
News
Hospital Management?
Product stageSegments
Go-to-Market
?
Healthcare analytics and business intelligence software
?

Health Data Analytics Institute (HDAI) is an artificial intelligence (AI) company that focuses on empowering clinicians, optimizing care pathways, and improving patient outcomes. The company has developed a predictive risk platform called HealthVision, which utilizes AI, machine learning (ML), and generative AI to analyze patient medical histories, quantify risks, and identify actionable clinical improvement opportunities.

HealthVision forecasts health risks at various levels, from individual patients to regional populations, and supports clinicians and healthcare institutions in driving performance improvements. The platform generates customized lists of patients who would benefit from case management or specific interventions, provides granular analyses of healthcare outcomes and costs compared to peers, and presents physicians with synthesized views of patients' medical histories and detailed risk profiles.

HDAI collaborates with leading health systems, such as Houston Methodist, Cleveland Clinic, and Dana-Farber Cancer Institute, as well as over 40 Medicare Accountable Care Organizations (ACOs), generating 50 million weekly predictions for one million patients as of October 2023. The company's implementation at Houston Methodist is one of the most comprehensive, system-wide AI/ML care optimization solutions in production, enabling data-informed actions by clinicians and population health managers.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
3 Allied Drive Suite 400 Dedham MA USA
Founded year:
2016
Employees:
11-50
IPO status:
Private
Total funding:
USD 47.0 mn
Last Funding:
USD 31.0 mn (Series C; Oct 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.